Company Overview and News

 
Where was KPMG, Wells Fargo’s auditor, while the funny business was going on? - MarketWatch

2018-04-07 marketwatch
KPMG wrote senators that it knew about the illegal activities for a while, but didn’t think they were that big of a deal
Upvote Downvote

1
Deciphering Immersion's 2018 Guidance

2018-03-05 seekingalpha
Immersion announced a global settlement with Apple just a couple of days before the ITC initial determination was due. Terms of the agreement are confidential.
Upvote Downvote

 
AAPL Stock Price - Apple Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

2018-01-29 marketwatch
Shares of Apple suppliers including Finisar Corp. and Qorvo Inc. fell in premarket trading Monday following some incrementally downbeat notes from analysts as well as a report from the Nikkei Asian Report saying that Apple was halving its March-quarter iPhone X production. Piper Jaffray analyst Troy Jensen downgraded shares of Finisar to neutral from overweight and lowered his price target to $20 from $28, citing his projection for "challenged" demand trends going forward.
Upvote Downvote

 
Immersion settles with Apple, reaches license agreements - MarketWatch

2018-01-29 marketwatch
Immersion Corp. IMMR, -3.04% said Monday it has entered into settlement and license deals with Apple Inc. AAPL, +0.23% Immersion, which develops touch feedback technology, had filed patent infringement lawsuits against Apple for technology used in iPhones and the trackpads used in MacBooks. Immersion said the terms of the agreements reached with Apple are confidential. The stock, which was still inactive in premarket trade, has tumbled 30% over the past 12 months, while the S&P 500 SPX, +1.
Upvote Downvote

1
Immersion enters settlement and license deal with Apple

2018-01-29 marketwatch
Immersion Corp. said Monday it has entered into settlement and license deals with Apple Inc. . Immersion, which develops touch feedback technology, had filed patent infringement lawsuits against Apple for technology used in iPhones and the trackpads used in MacBooks. Immersion said the terms of the agreements reached with Apple are confidential. The stock, which was still inactive in premarket trade, has tumbled 30% over the past 12 months, while the S&P 500 has gained 25%.
Upvote Downvote

1
BRIEF-Viex Capital Sent Demand Letter To Immersion To Inspect Certain Books And Records - SEC Filing

2018-01-23 reuters
* VIEX CAPITAL ADVISORS LLC SAYS ON JANUARY 5, SENT DEMAND LETTER TO IMMERSION CORP DEMANDING TO INSPECT CERTAIN BOOKS AND RECORDS - SEC FILING
Upvote Downvote

 
BRIEF-Immersion Corporation Announces Restructuring

2017-12-20 reuters
* IMMERSION - PLANS TO SIGNIFICANTLY REDUCE PRESENCE IN CHINA TO FOCUS PRIMARILY ON MOBILE OEM LICENSING
Upvote Downvote

1
IMMR / Immersion Corporation - Stock Institutional Ownership and Shareholders - Fintel.io

2017-12-04 fintel.io
Immersion Corporation (NASDAQ:IMMR) has 79 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,931,663 shares. Largest shareholders include Senvest Management, LLC, Raging Capital Management, LLC, Kingdom Ridge Capital Master Fund, Ltd., BlackRock Inc., VIEX Capital Advisors, LLC, Kingdom Ridge Capital, LLC, Vident Investment Advisory, LLC, Vanguard Group Inc, Kingdom Ridge Capital, LLC, and Shannon River Fund Management LLC.
Upvote Downvote

1
BRIEF-Immersion Corp Appoints Carl Schlachte As Interim CEO

2017-11-30 reuters
* IMMERSION CORP - APPOINTMENT OF CARL SCHLACHTE, CHAIRMAN OF BOARD, AS INTERIM CHIEF EXECUTIVE OFFICER
Upvote Downvote

 
BRIEF-Immersion announces multi-year licensing agreement with Nippon Seiki

2017-11-21 reuters
* Immersion Corp - ‍ Nippon Seiki to incorporate immersion’s haptics IP into its office solutions​ Source text for Eikon: Further company coverage:
Upvote Downvote

3
VIEX Capital Advisors, LLC - Current Holdings - Fintel.io

2017-10-11 fintel.io
VIEX Capital Advisors, LLC has disclosed 25 total holdings in their latest SEC filings. Portfolio manager(s) are listed as Eric Singer. Most recent portfolio value is calculated to be $ 180,798,000 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). VIEX Capital Advisors, LLC's top holdings are Quantum Corp. (NYSE:QTM) , YuMe, Inc. (NYSE:YUME) , Finisar Corporation (NASDAQ:FNSR) , Immersion Corporation (NASDAQ:IMMR) , and Bazaarvoice, Inc.
Upvote Downvote

 
Kingdom Ridge Capital Master Fund, Ltd. discloses 9.44% ownership in IMMR / Immersion Corporation - Fintel.io

2017-09-13 fintel.io
September 13, 2017 - Kingdom Ridge Capital Master Fund, Ltd. has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,761,000 shares of Immersion Corporation (NASDAQ:IMMR). This represents 9.44 percent ownership of the company.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...